Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model

Bindels, Laure;Beck, Raphaël;Schakman, Olivier;Martin, Jennifer C;Delzenne, Nathalie;et.al.
(2012) PLoS One — Vol. 7, n° 6, p. e37971 [1-10] (2012)

Files

BindelsPlosOne.pdf
  • Open Access
  • Adobe PDF
  • 621.79 KB

Details

Authors
  • Author
  • Beck, RaphaëlUCLouvain
    Author
  • Author
  • Martin, Jennifer C
    Author
  • De Backer, FabienneUCLouvain
    Author
  • Sohet, Florence M.UCLouvain
    Author
  • Dewulf, EvelyneUCLouvain
    Author
  • Pachikian, Barbara D.orcid-logoUCLouvain
    Author
  • Author
  • Thissen, Jean-Paulorcid-logoUCLouvain
    Author
  • Verrax, JulienUCLouvain
    Author
  • Buc Calderon, PedroUCLouvain
    Author
  • Cani, Patriceorcid-logoUCLouvain
    Author
  • Author
Show more
Abstract
The gut microbiota has recently been proposed as a novel component in the regulation of host homeostasis and immunity. We have assessed for the first time the role of the gut microbiota in a mouse model of leukemia (transplantation of BaF3 cells containing ectopic expression of Bcr-Abl), characterized at the final stage by a loss of fat mass, muscle atrophy, anorexia and inflammation. The gut microbial 16S rDNA analysis, using PCR-Denaturating Gradient Gel Electrophoresis and quantitative PCR, reveals a dysbiosis and a selective modulation of Lactobacillus spp. (decrease of L. reuteri and L. johnsonii/gasseri in favor of L. murinus/animalis) in the BaF3 mice compared to the controls. The restoration of Lactobacillus species by oral supplementation with L. reuteri 100-23 and L. gasseri 311476 reduced the expression of atrophy markers (Atrogin-1, MuRF1, LC3, Cathepsin L) in the gastrocnemius and in the tibialis, a phenomenon correlated with a decrease of inflammatory cytokines (interleukin-6, monocyte chemoattractant protein-1, interleukin-4, granulocyte colony-stimulating factor, quantified by multiplex immuno-assay). These positive effects are strain- and/or species-specific since L. acidophilus NCFM supplementation does not impact on muscle atrophy markers and systemic inflammation. Altogether, these results suggest that the gut microbiota could constitute a novel therapeutic target in the management of leukemia-associated inflammation and related disorders in the muscle.
Affiliations

Citations

Bindels, L., Beck, R., Schakman, O., Martin, J. C., De Backer, F., Sohet, F. M., Dewulf, E., Pachikian, B. D., Neyrinck, A., Thissen, J.-P., Verrax, J., Buc Calderon, P., Pot, B., Grangette, C., Cani, P., Scott, K. P., & Delzenne, N. (2012). Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One, 7(6), e37971 [1-10]. https://doi.org/10.1371/journal.pone.0037971 (Original work published 2012)